Keywords: fda, clears, first, one-dose, otc, thrush, therapy
FDA Clears First One-Dose OTC Thrush Therapy
Article | 24 February 1997
Bristol-Myers Squibb has been granted marketing clearance from the USFood and Drug Administration for the over-the-counter use of Vagistat-1 ointment ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
